View of Optimization of stability indicating RP-HPLC method for the estimation of an anti-cancer drug Sorafenib Tosylate in pure and pharmaceutical dosage form

View of Optimization of stability indicating RP-HPLC method for the estimation of an anti-cancer drug Sorafenib Tosylate in pure and pharmaceutical dosage form

Return to Article Details Optimization of stability indicating RP-HPLC method for the estimation of an anti-cancer drug Sorafenib Tosylate in pure and pharmaceutical dosage form Download Download PDF